Neuronetics, Inc

Neuronetics Study Shows Strong Antidepressant Results for Teens and Young Adults Using NeuroStar TMS

MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced new real-world data demonstrating that its NeuroStar transcranial magnetic stimulation (TMS) therapy delivers meaningful improvement in depression symptoms among adolescents and young adults. …

Neuronetics Study Shows Strong Antidepressant Results for Teens and Young Adults Using NeuroStar TMS Read More



Windtree Therapeutics

Windtree Therapeutics Secures $520 Million in Equity Agreements to Expand BNB Cryptocurrency Holdings

WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) announced two major equity financing agreements totaling up to $520 million, positioning the company to significantly expand its holdings of BNB cryptocurrency, …

Windtree Therapeutics Secures $520 Million in Equity Agreements to Expand BNB Cryptocurrency Holdings Read More